Safety and Effects of Ashwagandha Root: Single Dose Study in Healthy Adults

Jenn Hoskins
20th February, 2025

Safety and Effects of Ashwagandha Root: Single Dose Study in Healthy Adults

Ashwagandha (Withania somnifera)

Photo adapted from: Luke Lythgoe / CC BY (Source)

Key Findings

  • In Mumbai, researchers found that a daily 400 mg dose of Ashwagandha is safe for healthy adults
  • The body quickly absorbs Ashwagandha’s key compounds, reaching peak levels within 1.5 hours
  • These results support further studies on Ashwagandha’s benefits for reducing stress and enhancing mental well-being
Stress is a prevalent issue affecting individuals worldwide, impacting mental health, physical well-being, and overall quality of life. Traditional medicine systems, such as Ayurveda, have long utilized adaptogenic herbs to help the body manage and adapt to stress. One such herb, Withania somnifera, commonly known as Ashwagandha, has gained significant attention for its potential benefits in stress management and overall health[2]. Ashwagandha is renowned for its adaptogenic properties, meaning it helps the body maintain balance and resist the harmful effects of stress. Previous research has demonstrated Ashwagandha's ability to reduce anxiety and depression-like behaviors in animal models[2]. Additionally, studies have explored the pharmacological effects of its active components, withanosides and withanolides, highlighting their potential health benefits. However, understanding the pharmacokinetics (how the body absorbs, distributes, metabolizes, and excretes a substance) and ensuring the safety of Ashwagandha in humans has been challenging due to the complex nature of its constituents[3]. Addressing this gap, a recent study conducted by Phytoveda Pvt. Ltd. in Mumbai, India[1], aimed to evaluate the pharmacokinetics, safety, and tolerability of Ashwagandha root extract in healthy male and female volunteers. This study is crucial as it provides foundational knowledge necessary for designing effective clinical trials and ensuring safe consumption of Ashwagandha supplements. The study utilized an open-label, single-dose clinical design, where participants received two capsules of Ashwagandha root extract, each containing 200 mg of the extract, totaling 400 mg. The focus was on four key bioactive compounds in Ashwagandha: withanoside IV, withaferin A, 12-deoxy-withastramonolide, and withanolide A. To accurately measure these compounds in the blood, the researchers employed a validated Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS) method, a sophisticated technique that ensures precise and reliable results. In addition to pharmacokinetic measurements, the study meticulously assessed the safety and tolerability of Ashwagandha. This involved monitoring vital signs, conducting tests for organ function, examining urine samples, performing X-rays, electrocardiograms (ECG), and tracking any adverse events reported by the participants. These comprehensive safety evaluations are vital to ensure that Ashwagandha can be consumed without causing harm. The results were promising. Participants reported normal physical, hematological, and biochemical parameters after taking Ashwagandha, with no abnormalities detected in safety metrics. This indicates that a daily dose of 400 mg is well-tolerated by healthy individuals. Regarding pharmacokinetics, the study provided detailed insights into how the body handles Ashwagandha's active compounds. The maximum concentration (Cmax) of the bioactives ranged between 0.472 and 4.468 ng/mL, and they reached their peak levels in the blood (Tmax) within approximately 0.25 to 1.42 hours after ingestion. The half-life (t1/2), which indicates how long it takes for the concentration of the drug to reduce by half, varied between 1.696 and 4.377 hours for the different compounds. These findings are essential for understanding the dosage and frequency needed to achieve optimal therapeutic effects. This study builds upon previous research that highlighted the challenges in analyzing Ashwagandha's constituents and their pharmacokinetic profiles[3]. By establishing a reliable method to quantify key bioactives in the blood and confirming the safety of Ashwagandha consumption, this research paves the way for more extensive clinical trials. Such trials can further explore Ashwagandha's potential benefits, including its capacity to enhance well-being, improve energy levels, and support mental clarity, as observed in a recent human trial involving college students[4]. In the qualitative study conducted with college students, participants who took Ashwagandha reported increased energy, better mental clarity, improved sleep quality, and reduced stress over a 30-day period[4]. These subjective improvements align with the pharmacological potential of Ashwagandha's active compounds, as demonstrated in both in vitro and in vivo studies[2]. The current pharmacokinetic and safety study provides the necessary groundwork to validate these positive experiences by ensuring that Ashwagandha can be safely incorporated into daily regimens. Furthermore, understanding the pharmacokinetics of Ashwagandha helps in optimizing its use as a nutraceutical. The ability of its constituents to be absorbed efficiently and reach therapeutic levels in the bloodstream is crucial for maximizing its benefits. Prior research indicated that Ashwagandha constituents have good oral bioavailability and can cross the blood-brain barrier, which is essential for their effects on stress and cognitive function[3]. The current study confirms these properties in humans, reinforcing the potential of Ashwagandha as a reliable adaptogen. In summary, the study by Phytoveda Pvt. Ltd. provides valuable insights into the pharmacokinetics, safety, and tolerability of Ashwagandha root extract in healthy individuals. By ensuring that a 400 mg dose is safe and understanding how the body processes its active compounds, this research supports the continued use and investigation of Ashwagandha as an effective adaptogen. This foundation is critical for future studies aiming to harness Ashwagandha's full potential in managing stress, enhancing mental clarity, and improving overall well-being.

HerbsMedicineHealth

References

Main Study

1) An open-label, single dose, safety and pharmacokinetic study of Withania somnifera root extract in healthy volunteers.

Published 19th February, 2025

https://doi.org/10.1515/dmpt-2024-0089

Related Studies

2) Efficacy and Anti-Inflammatory Activity of Ashwagandha Sustained-Release Formulation on Depression and Anxiety Induced by Chronic Unpredictable Stress: in vivo and in vitro Studies.

https://doi.org/10.2147/JEP.S407906

3) Pharmacokinetic Study of Withanosides and Withanolides from Withania somnifera Using Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry (UHPLC-MS/MS).

https://doi.org/10.3390/molecules27051476

4) The Perceived Impact of Ashwagandha on Stress, Sleep Quality, Energy, and Mental Clarity for College Students: Qualitative Analysis of a Double-Blind Randomized Control Trial.

https://doi.org/10.1089/jmf.2022.0042


Related Articles

An unhandled error has occurred. Reload 🗙